Luthringer Remy
SEC insider (Form 3/4/5 filer). CIK 0001610384. CEO at Minerva Neurosciences, Inc. (NERV). 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 3, 2026. Located in BURLINGTON, MA.
Companies Luthringer Remy has filed insider reports for
- Minerva Neurosciences, Inc. (NERV): Director, Officer, CEO
Luthringer Remy
CIK: 0001610384
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Minerva Neurosciences, Inc.
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jun 3, 2026NERV
Minerva Neurosciences, Inc.
AwardDirectEmployee Stock Option (right to buy)
1.7M shares- - Dec 22, 2025NERV
Minerva Neurosciences, Inc.
AwardDirectEmployee Stock Option (right to buy)
2.3M shares- - Dec 5, 2024NERV
Minerva Neurosciences, Inc.
AwardDirectEmployee Stock Option (right to buy)
105K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 3, 2026 | NERV Minerva Neurosciences, Inc. | Award Employee Stock Option (right to buy) | 1,690,700 | - | - | Direct |
| Dec 22, 2025 | NERV Minerva Neurosciences, Inc. | Award Employee Stock Option (right to buy) | 2,250,000 | - | - | Direct |
| Dec 5, 2024 | NERV Minerva Neurosciences, Inc. | Award Employee Stock Option (right to buy) | 105,000 | - | - | Direct |
1-3 of 3 transactions